Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta.

Ploix C, Zuberi RI, Liu FT, Carson MJ, Lo DD. Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta. Int J Med Sci. 2009; 6(2):85-92.

View in: PubMed

authors with profiles

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support